Skip to content
value.today

Rivermark Medical, Inc.

Total raised
$36 M
3 rounds on record
Latest round
$30 M
Sep 2024
First round on record
Nov 2021
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Rivermark Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2024$30 MNo. 3$10 to $50 million

Rivermark Medical, Inc.: Raise no. 3, Sep 2024

Investors in this round

16 investors had bought by the notice of Oct 11, 2024: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$30 M of $30 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Kadlec · Executive Officer, Director
  • Anand Doraiswamy · Executive Officer, Director
  • Carter Meyer · Director
  • Joseph Biller · Director
  • Josh Baltzell · Director
  • Matthew Ercolani · Director
  • Scott Button · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adam Kadlec, Chief Executive Officer and President. Source: SEC Form D, newest notice filed Oct 11, 2024. Read the notice at the SEC.

equitySEC
Jul 2023$4 MNo. 2$2 to $10 million

Rivermark Medical, Inc.: Raise no. 2, Jul 2023

Investors in this round

6 investors had bought by the notice of Oct 11, 2024: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Kadlec · Executive Officer, Director
  • Anand Doraiswamy · Executive Officer, Director
  • Carter Meyer · Director
  • Joseph Biller · Director
  • Josh Baltzell · Director
  • Matthew Ercolani · Director
  • Scott Button · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adam Kadlec, Chief Executive Officer and President. Source: SEC Form D and 1 amendment, newest notice filed Oct 11, 2024. Read the notice at the SEC.

equitySEC
Nov 2021$2 MNo. 1Under $2 million

Rivermark Medical, Inc.: Raise no. 1, Nov 2021

Investors in this round

5 investors had bought by the notice of Nov 19, 2021: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Adam Kadlec · Executive Officer, Director
  • Anand Doraiswamy · Executive Officer, Director
  • Carter Meyer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Adam Kadlec, Chief Executive Officer and President. Source: SEC Form D, newest notice filed Nov 19, 2021. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Rivermark Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2024).

    SEC Form D · Oct 2024

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Oct 2024

That is all the official record says: Rivermark Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Rivermark Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 16 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Rivermark Medical, Inc.
NameRoleNamed in
Adam KadlecExecutive officerOct 2024
Anand DoraiswamyExecutive officerOct 2024
Adam KadlecDirectorOct 2024
Anand DoraiswamyDirectorOct 2024
Carter MeyerDirectorOct 2024
Joseph BillerDirectorOct 2024
Josh BaltzellDirectorOct 2024
Matthew ErcolaniDirectorOct 2024
Scott ButtonDirectorOct 2024
Christopher KasterDirectorJul 2023